Gene-by-environment effect of house dust mite on purinergic receptor P2Y12 (P2RY12) and lung function in children

S Bunyavanich1, J A Boyce, B A Raby

  • 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. supinda@post.harvard.edu

Abstract

Insights

Genetic variants in the P2Y12 gene (P2RY12) are linked to lung function in children with asthma. House dust mite exposure significantly impacts this relationship, suggesting P2Y12 as a potential asthma treatment target.

Area of Science:

  • Immunology
  • Genetics
  • Pulmonology

Background:

  • Leukotriene E4 (LTE4) is a key mediator in airway inflammation.
  • Purinergic receptor P2Y12 (P2Y12) plays a role in LTE4-induced inflammation and experimental asthma models.
  • The role of P2Y12 in human asthma has not been previously investigated.

Purpose of the Study:

  • To investigate the association between P2Y12 gene variants and lung function in asthmatic children.
  • To explore potential gene-environment interactions with house dust mite exposure.

Main Methods:

  • Genotyping of 19 single nucleotide polymorphisms (SNPs) in the P2RY12 gene in 422 children with asthma and their families (n=1266).
  • Family-based association analyses were conducted for lung function measures.
  • Haplotype and gene-environment interaction analyses, specifically with house dust mite exposure, were performed.

Main Results:

  • Five P2RY12 SNPs showed significant associations with multiple lung function measures (P<0.025).
  • P2RY12 haplotypes were also significantly associated with lung function (P<0.046).
  • Significant gene-environment interactions were observed, where house dust mite exposure worsened lung function in minor allele homozygotes (P<0.040).

Conclusions:

  • P2RY12 variants are associated with lung function in a large family-based asthma cohort.
  • House dust mite exposure significantly modifies the effect of P2RY12 on lung function.
  • These findings provide the first human evidence supporting P2Y12's role in lung function and suggest it as a novel therapeutic target for asthma.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Gene-Environment Interactions01:20

Gene-Environment Interactions

Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...